MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-21-2026
Check-Cap Ltd. EV/EBITDA Ratio 2011-2026 | CHEK
Annual EV/EBITDA Ratio Check-Cap Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.674 | -0.52 | -0.868 | -2.47 | -1.22 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.52 | -2.47 | -1.15 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
26.4 | $ 9.2 | 2.17 % | $ 613 M |  USA |
|
Biodesix
BDSX
|
-4.25 | $ 15.36 | 4.56 % | $ 1.99 B | USA |
 |
Biomerica
BMRA
|
-6.24 | $ 2.14 | 0.47 % | $ 4.92 M | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 16.25 | -0.49 % | $ 491 M | USA |
 |
Guardant Health
GH
|
-28.8 | $ 83.44 | -1.79 % | $ 10.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
38 | $ 102.22 | 1.86 % | $ 8.43 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 572.04 | -1.12 % | $ 46 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 74.38 | -1.79 % | $ 5.02 B | USA |
 |
Medpace Holdings
MEDP
|
30.7 | $ 463.54 | 1.45 % | $ 13.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 4.67 | 0.11 % | $ 432 M | USA |
 |
National Research Corporation
NRC
|
21 | $ 17.35 | -0.91 % | $ 388 M | USA |
 |
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.39 | -0.36 % | $ 417 M | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Precipio
PRPO
|
-1.8 | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Personalis
PSNL
|
-7.07 | $ 7.71 | 1.31 % | $ 457 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
RadNet
RDNT
|
17.6 | $ 59.66 | -3.37 % | $ 4.49 B | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 159.73 | 1.09 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 165.68 | -0.77 % | $ 28.5 B | USA |
 |
Sotera Health Company
SHC
|
24.8 | $ 13.83 | -0.36 % | $ 3.93 B | USA |
 |
Soleno Therapeutics
SLNO
|
0.12 | $ 31.01 | -2.24 % | $ 1.58 B | USA |
 |
Neuronetics
STIM
|
-1.45 | $ 1.45 | -9.69 % | $ 95.6 M | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.23 | -15.75 % | $ 6.7 M | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 263.12 | 1.94 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
70.5 | $ 125.57 | 1.44 % | $ 20 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
-23.6 | $ 46.42 | 4.31 % | $ 2.78 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 101.62 | -4.81 % | $ 4.01 B | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 267.18 | 1.04 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K |  Israel |
 |
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 7.91 | -2.41 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
-19.5 | $ 194.73 | -2.68 % | $ 19.2 B | USA |
 |
Senseonics Holdings
SENS
|
-13.8 | $ 6.62 | - | $ 276 M | USA |